Pediatrics

Efficacy and safety of short- versus standard-course ceftriaxone therapy in children with pneumonia: A randomized trial. | ClinicLens

Pediatric bacterial pneumonia (30-40% of cases) is commonly treated with ceftriaxone sodium, but optimal duration (traditional 7-14 days vs. short 5-7 days) remains controversial. To compare therapeutic efficacy, inflammatory marker dynamics and safety of short- vs. standard-cour

Medical Literature · Updated

← Back to articles
This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.